ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Taipei City, TWN:

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer (DB-07)

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 71 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Taipei, Taiwan and 324 other locations

Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer pa ...

Enrolling
Breast Cancer
Other: Placebo
Dietary Supplement: Probiotic
GenMont Biotech

Taipei, Taiwan

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 147 other locations

DESTINY-Breast 08 will investigate the safety, tolerability, PK and preliminary anti-tumour activity of T-DXd in combination with other ther ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Durvalumab

Phase 1

AstraZeneca
AstraZeneca

Taipei, Taiwan and 36 other locations

with LC vs. EC in chemo-naive Her2-patients with stage I or II breast cancerSecondary objectives:* To assess the overall survival (...

Active, not recruiting
Breast Cancer
Drug: liposomal-doxorubicin+Cyclophosphamide
Drug: Epirubicin+Cyclophosphamide

Phase 2

TTY Biopharm

Taipei, Taiwan and 8 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Vinorelbine
Drug: Eribulin

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 166 other locations

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: faslodex dummy
Drug: arimidex dummy

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 118 other locations

Olaparib, a PARP inhibitor, is proven as an effective therapy for germline BRCA1/2-mutated breast cancer; however, the therapeutic ...

Enrolling
Metastatic Breast Cancer
Drug: Chemotherapy drug
Drug: Olaparib

Phase 2

National Taiwan University
National Taiwan University

Taipei, Please Select, Taiwan and 2 other locations

versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Taipei, Taiwan and 163 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems